FDA
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Vera Therapeutics (VERA)
-
-
-
-
-
-
-
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $95 at Goldman Sachs
-
-
-
-
-
-
-
Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Evercore ISI Reiterates Outperform Rating on Vera Therapeutics (VERA)
-
-
-
-
-
-
-
Vera Therapeutics Inc. (VERA) Reports Q4, Provides Business Update
-
-
-
-
-
-
-
Vera Therapeutics (VERA) Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
-
326,461 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

